Sontuzumab
N/A
Report date: 2023/04/21 13:58:40
Base Information
Drug NameSontuzumab
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research UK
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesAntisoma Research LtdNational Cancer InstituteBiothera Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A